Objective: To examine if, during conversion from conventional divalproex to once-daily divalproex extended-release (ER) tablets, plasma valproic acid (VPA) concentrations in the first 48 hours after ...

Divalproex (Divalrate ER) is an anticonvulsant, prescribed for bipolar disorder, epilepsy and to prevent migraine headache. It controls the abnormal activity of nerve impulses in the brain and central ...

Divalproex sodium 250mg, 500mg; ext-rel tabs. Divalproex sodium dissociates to the valproate ion in the gastrointestinal tract. The mechanisms by which valproate exerts its therapeutic effects have ...

The US Food and Drug Administration (FDA) has approved a new indication for Abbott Laboratories' Depakote ER (divalproex sodium extended-release tablets), the treatment of acute manic or mixed ...

Divalproex (Divalin ER (500 mg)) is an anticonvulsant, prescribed for bipolar disorder, epilepsy and to prevent migraine headache.It controls the abnormal activity of nerve impulses in the brain and ...

Dr. Gary J. Kennedy answers the question: 'Divalproex For Bipolar Disorder?' — -- Question: How is divalproex (Depakote) used in the treatment of bipolar disorder, and what are the side effects ...

ROCKVILLE, Md. The Food and Drug Administration has approved two generic versions of Abbott’s epilepsy and bipolar disorder drug Depakote ER, agency records show. The FDA gave tenative approval to ...

NEW YORK AP – Generic drug developer Mylan Inc. said Thursday that a subsidiary has entered into a settlement and license agreement with Abbott Laboratories relating to a generic version of Abbott’s ...

Since 1983, Depakote ER has been a good source of revenue for drug manufacturers. But is its future as sunny? Since 1983, Depakote ER has been a good source of revenue for drug manufacturers. The drug ...

Depakote is a medication that contains divalproex sodium. It can treat seizures, mania, and migraine headaches. Thrombocytopenia is a potential side effect. The molecule divalproex sodium breaks down ...

NEW YORK, June 5 (Reuters) - Mylan Inc said on Thursday it settled patent litigation with Abbott Laboratories Inc over Abbott's Depakote ER drug for epilepsy and bipolar disorder that allows the ...

Particular attention should be focused on patients concomitantly taking enzyme-inducing AEDs converting from divalproex q12h to divalproex ER once daily who could be instructed by their clinician to ...